Agency Information Collection Activities: Proposed Collection; Comment Request, 36317-36319 [2023-11723]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 106 / Friday, June 2, 2023 / Notices
umbilicals, and other equipment prior
to disconnection. No releases or
discharges of fluid from pipelines,
umbilicals, and/or other equipment that
have not been fully flushed prior to
being disconnected or cut from the
facility are authorized under this
NPDES permit.
16. Calculation for WET critical
dilutions and testing frequencies is
based on calendar year.
17. Waiver for the minimum number
of samples to be collected for WET tests,
should the effluent cease discharging for
produced water.
18. For Treatment, Completion, and
Workover discharges, acute WET results
can be derived from chronic WET test.
19. Compliance schedule for WET
acute limits related to Treatment,
Completion, and Workover discharges
and sample holding time of 72 hours.
20. No approved Alternative Test
Procedure (ATP) for WET, however they
can be requested at any time following
40 CFR 136.5.
21. 72 hour hold time for WET
samples for Chemically Treated
Miscellaneous Discharges.
22. For Chemically Treated
Miscellaneous Discharges, noncontinuous discharges are discharges
that occur less than or equal to once per
week and last less than 24 hours. These
discharges shall be monitored once per
discharge.
23. State general permit or state
individual permit may be required in
addition to authorization under this
permit.
24. Defines decommissioning and
Subsea Cleaning Fluids.
25. 7-day chronic toxicity
requirements for Well Treatment Fluids,
Completion Fluids, and Workover
Fluids has been moved from limitations
to monitoring section, to provide clarity
that chronic is monitoring only.
26. Free oil language has been
updated to reference DMRs and twentyfour hour reporting requirements.
27. Part I.C. reflects Other Limitations,
Prohibitions and Discharges not
Authorized. Moved Limitations on
Coverage section in Part I.A.1 to Part I.C
for Prohibitions and Discharges Not
Authorized.
28. Permit does not authorize
radioactive materials that are under the
jurisdiction of the NRC.
29. Miscellaneous Discharges of Water
Which Have Been Chemically Treated
includes discharges from well
operations other than those covered by
other sections of Part I.B of the permit.
30. Corrections to the Permit
Summary Table. Table is for reference
only.
31. Corrected data for Discharge
Monitoring Reports (DMRs) and Other
VerDate Sep<11>2014
17:34 Jun 01, 2023
Jkt 259001
Reports must be submitted as soon as
the error has been identified but no later
than the following quarter. Submittal of
corrected data does not excuse any
permit violation.
32. If Offshore 24-Hour Reporting
Application Portal is not available, an
email shall be sent within 24 hours of
occurrence of specified violations and
electronic report shall be submitted
within 14 days of the system becoming
available.
33. A facility map that delineates
authorized discharge locations and type
must be submitted, as an attachment,
when filing the eNOI.
34. Language has been updated to
specify that new operators are not
eligible for coverage and existing
operators may not submit new NOI’s
during the administraive continued
period.
35. Updated language to provide
clarity that timely updates to ‘‘CDX’’ are
required, in lieu of ‘‘eNOI.’’
36. Numeric exceedances of
maximum through-screen design intake
velocity and dates must also be
included on DMRs, for all new facilities
required to comply with intake structure
monitoring requirements.
37. Definition of Mobile Offshore
Drilling Unit (MODU) has been removed
from the permit because it does not exist
in the Code of Federal Regulations. Part
I.A.2 has been updated to provide
examples of MODUs.
38. Civil and administrative penalty
amounts have been updated to reflect
updated statutory amounts.
39. Once a month temperature
monitoring for produced water.
II. Other Legal Requirements
Other statutory and regulatory
requirements are discussed in the fact
sheet that include: Oil Spill
Requirement; Ocean Discharge Criteria
Evaluation; Marine Protection,
Research, and Sanctuaries Act; National
Environmental Policy Act; MagnusonStevens Fisheries Conservation and
Management Act; Endangered Species
Act; State Water Quality Standards and
State Certification; Coastal Zone
Management Act; and Paperwork
Reduction Act.
Under Executive Order 12866 (58 FR
51735, October 4, 1993), this action is a
‘‘significant regulatory action.’’
Accordingly, EPA submitted this action
to the Office of Management and Budget
(OMB) for review under Executive
Orders 12866 and 13563 (76 FR 3821,
January 21, 2011) and any changes made
in response to OMB recommendations
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
36317
have been documented in the docket for
this action.
Charles W. Maguire,
Director, Water Division, EPA Region 6.
[FR Doc. 2023–11770 Filed 6–1–23; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project ‘‘AHRQ
Research Reporting System (ARRS).’’
This proposed information collection
was previously published in the Federal
Register on March 29th, 2023 and
allowed 60 days for public comment.
AHRQ received no substantive
comments from members of the public.
The purpose of this notice is to allow an
additional 30 days for public comment.
DATES: Comments on this notice must be
received by July 3, 2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Proposed Project
AHRQ Research Reporting System
(ARRS)
AHRQ has developed a systematic
method for its grantees to report project
progress and important preliminary
findings for grants funded by the
E:\FR\FM\02JNN1.SGM
02JNN1
36318
Federal Register / Vol. 88, No. 106 / Friday, June 2, 2023 / Notices
Agency. This system, the AHRQ
Research Reporting System (ARRS),
previously known as the Grants
Reporting System (GRS), was last
approved by OMB on August 31, 2020.
The system addressed the shortfalls in
the previous reporting process and
established a consistent and
comprehensive reporting solution for
grants in AHRQ. The ARRS provides a
centralized repository of grants research
progress and additional information that
can be used to support initiatives within
the Agency. This includes future
research planning and support for
administrative activities such as
performance monitoring, budgeting, and
knowledge transfer, as well as for
strategic planning.
This Project has the following goals:
(1) To promote the transfer of critical
information more frequently and
efficiently and enhance the Agency’s
ability to support research designed to
improve the outcomes and quality of
health care, reduce its costs, and
broaden access to effective services
(2) To increase the efficiency of the
Agency in responding to ad-hoc
information requests
(3) To support Executive Branch
requirements for increased transparency
and public reporting
(4) To establish a consistent approach
throughout the Agency for information
collection regarding grant progress and
a systematic basis for oversight and for
facilitating potential collaborations
among grantees
(5) To decrease the inconvenience and
burden on grantees of unanticipated adhoc requests for information by the
Agency in response to particular (onetime) internal and external requests for
information
This project is being conducted by
AHRQ through its contractor, Science
Applications International Corporation,
Inc, pursuant to AHRQ’s statutory
authority to conduct and support
research on health care and on systems
for the delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness, and value of healthcare
services and with respect to quality
measurement and improvement. 42
U.S.C 299a(a)(1) and (2).
Method of Collection
Grantees use the ARRS system to
report project progress and important
preliminary findings for grants funded
by the Agency. Grantees submit progress
reports on a monthly or quarterly basis,
which are reviewed by AHRQ
personnel. All users access the ARRS
system through a secure online interface
which requires a user id and password
entered through the ARRS Login screen.
When status reports are due AHRQ
notifies Principal Investigators (PI) via
email.
The ARRS is an automated userfriendly resource that is utilized by
AHRQ staff for preparing, distributing,
and reviewing reporting requests to
grantees for the purpose of information
sharing. AHRQ personnel are able to
systematically search the information
collected and stored in the ARRS
database. Personnel will also use the
information to address internal and/or
external requests for information
regarding grant progress, preliminary
findings, and other requests, such as
Freedom of Information Act requests,
and producing responses related to
federally mandated programs and
regulations.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours for the
respondents. It will take grantees an
estimated 15 minutes to enter the
necessary data into the ARRS System.
Frequency of reporting varies from
monthly to once a year. The total
number of responses submitted for the
past year is considered for this
estimation. Based on that, the total
annualized burden hours are estimated
to be 125 hours.
Exhibit 2 shows the estimated
annualized cost burden for the
respondents. The total estimated cost
burden for respondents is $5,475.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
Form name
Hours per
response
Total burden
hours
Data entry into ARRS ..................................................................................................................
500
15/60
125
Total ......................................................................................................................................
500
N/A
125
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
responses
Form name
Total burden
hours
Average
hourly
wage rate *
Total cost
burden
Data entry into ARRS ......................................................................................
500
125
$43.80
$5,475
Total ..........................................................................................................
500
125
N/A
$5,475
* Based upon the average wages for Healthcare Practitioner and Technical Occupations (29–0000), ‘‘National Compensation Survey: Occupational Wages in the United States, May 2021,’’ U.S. Department of Labor, Bureau of Labor Statistics, https://www.bls.gov/oes/current/oes_
nat.htm#29-0000.
lotter on DSK11XQN23PROD with NOTICES1
Request for Comments
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
VerDate Sep<11>2014
17:34 Jun 01, 2023
Jkt 259001
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
E:\FR\FM\02JNN1.SGM
02JNN1
Federal Register / Vol. 88, No. 106 / Friday, June 2, 2023 / Notices
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
proposed information collection. All
comments will become a matter of
public record.
Dated: May 26, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–11723 Filed 6–1–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–D–0322]
Action Level for Inorganic Arsenic in
Apple Juice: Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of a final
guidance for industry entitled ‘‘Action
Level for Inorganic Arsenic in Apple
Juice.’’ The guidance identifies for
industry an action level for inorganic
arsenic in apple juice that is intended to
help protect public health by reducing
exposure to inorganic arsenic and is
achievable with the use of current good
manufacturing practices. It also
describes our intended sampling and
enforcement approach. Thus, the
guidance finalizes the approach
presented in the draft guidance issued
in 2013.
DATES: The announcement of the
guidance is published in the Federal
Register on June 2, 2023.
ADDRESSES: You may submit either
electronic or written comments on FDA
guidances at any time as follows:
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
VerDate Sep<11>2014
17:34 Jun 01, 2023
Jkt 259001
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2012–D–0322 for ‘‘Action Level for
Inorganic Arsenic in Apple Juice:
Guidance for Industry.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ We
will review this copy, including the
claimed confidential information, in our
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
36319
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the Division of
Plant Products and Beverages, Office of
Food Safety, Center for Food Safety and
Applied Nutrition (HFS–317), Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740. Send two selfaddressed adhesive labels to assist that
office in processing your request. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance.
FOR FURTHER INFORMATION CONTACT:
Eileen Abt, Center for Food Safety and
Applied Nutrition (HFS–317), Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–1529;
or Denise See, Center for Food Safety
and Applied Nutrition, Office of
Regulations and Policy (HFS–024), Food
and Drug Administration, 5001 Campus
Dr., College Park, MD 20740, 240–402–
2378.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of
a guidance for industry entitled ‘‘Action
Level for Inorganic Arsenic in Apple
Juice.’’ We are issuing this guidance
consistent with our good guidance
practices regulation (21 CFR 10.115).
The guidance represents the current
thinking of FDA on this topic. It does
not establish any rights for any person
and is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations.
In the Federal Register of July 15,
2013 (78 FR 42086), we announced the
availability of a draft guidance for
industry entitled ‘‘Arsenic in Apple
Juice: Action Level.’’ We also
announced the availability of two
related scientific documents: a
document entitled ‘‘Supporting
Document for Action Level for Arsenic
in Apple Juice’’ (supporting document),
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 88, Number 106 (Friday, June 2, 2023)]
[Notices]
[Pages 36317-36319]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11723]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project ``AHRQ Research Reporting System (ARRS).'' This proposed
information collection was previously published in the Federal Register
on March 29th, 2023 and allowed 60 days for public comment. AHRQ
received no substantive comments from members of the public. The
purpose of this notice is to allow an additional 30 days for public
comment.
DATES: Comments on this notice must be received by July 3, 2023.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
[email protected].
SUPPLEMENTARY INFORMATION:
Proposed Project
AHRQ Research Reporting System (ARRS)
AHRQ has developed a systematic method for its grantees to report
project progress and important preliminary findings for grants funded
by the
[[Page 36318]]
Agency. This system, the AHRQ Research Reporting System (ARRS),
previously known as the Grants Reporting System (GRS), was last
approved by OMB on August 31, 2020. The system addressed the shortfalls
in the previous reporting process and established a consistent and
comprehensive reporting solution for grants in AHRQ. The ARRS provides
a centralized repository of grants research progress and additional
information that can be used to support initiatives within the Agency.
This includes future research planning and support for administrative
activities such as performance monitoring, budgeting, and knowledge
transfer, as well as for strategic planning.
This Project has the following goals:
(1) To promote the transfer of critical information more frequently
and efficiently and enhance the Agency's ability to support research
designed to improve the outcomes and quality of health care, reduce its
costs, and broaden access to effective services
(2) To increase the efficiency of the Agency in responding to ad-
hoc information requests
(3) To support Executive Branch requirements for increased
transparency and public reporting
(4) To establish a consistent approach throughout the Agency for
information collection regarding grant progress and a systematic basis
for oversight and for facilitating potential collaborations among
grantees
(5) To decrease the inconvenience and burden on grantees of
unanticipated ad-hoc requests for information by the Agency in response
to particular (one-time) internal and external requests for information
This project is being conducted by AHRQ through its contractor,
Science Applications International Corporation, Inc, pursuant to AHRQ's
statutory authority to conduct and support research on health care and
on systems for the delivery of such care, including activities with
respect to the quality, effectiveness, efficiency, appropriateness, and
value of healthcare services and with respect to quality measurement
and improvement. 42 U.S.C 299a(a)(1) and (2).
Method of Collection
Grantees use the ARRS system to report project progress and
important preliminary findings for grants funded by the Agency.
Grantees submit progress reports on a monthly or quarterly basis, which
are reviewed by AHRQ personnel. All users access the ARRS system
through a secure online interface which requires a user id and password
entered through the ARRS Login screen. When status reports are due AHRQ
notifies Principal Investigators (PI) via email.
The ARRS is an automated user-friendly resource that is utilized by
AHRQ staff for preparing, distributing, and reviewing reporting
requests to grantees for the purpose of information sharing. AHRQ
personnel are able to systematically search the information collected
and stored in the ARRS database. Personnel will also use the
information to address internal and/or external requests for
information regarding grant progress, preliminary findings, and other
requests, such as Freedom of Information Act requests, and producing
responses related to federally mandated programs and regulations.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden hours for the
respondents. It will take grantees an estimated 15 minutes to enter the
necessary data into the ARRS System. Frequency of reporting varies from
monthly to once a year. The total number of responses submitted for the
past year is considered for this estimation. Based on that, the total
annualized burden hours are estimated to be 125 hours.
Exhibit 2 shows the estimated annualized cost burden for the
respondents. The total estimated cost burden for respondents is $5,475.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Hours per Total burden
Form name responses response hours
----------------------------------------------------------------------------------------------------------------
Data entry into ARRS............................................ 500 15/60 125
-----------------------------------------------
Total....................................................... 500 N/A 125
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Average
Form name Number of Total burden hourly wage Total cost
responses hours rate * burden
----------------------------------------------------------------------------------------------------------------
Data entry into ARRS............................ 500 125 $43.80 $5,475
---------------------------------------------------------------
Total....................................... 500 125 N/A $5,475
----------------------------------------------------------------------------------------------------------------
* Based upon the average wages for Healthcare Practitioner and Technical Occupations (29-0000), ``National
Compensation Survey: Occupational Wages in the United States, May 2021,'' U.S. Department of Labor, Bureau of
Labor Statistics, https://www.bls.gov/oes/current/oes_nat.htm#29-0000.
Request for Comments
In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501-
3520, comments on AHRQ's information collection are requested with
regard to any of the following: (a) whether the proposed collection of
information is necessary for the proper performance of AHRQ's health
care research and health care information dissemination functions,
including whether the information will have practical utility; (b) the
accuracy of AHRQ's estimate of burden (including hours and costs) of
the proposed collection(s) of information; (c) ways to enhance the
quality, utility and clarity of the information to be collected; and
(d) ways to minimize the burden of the collection of information upon
the respondents, including the use of automated collection techniques
or other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
[[Page 36319]]
proposed information collection. All comments will become a matter of
public record.
Dated: May 26, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-11723 Filed 6-1-23; 8:45 am]
BILLING CODE 4160-90-P
